Condensed Consolidating Statement of Cash Flows (Details) (USD $) | 6 Months Ended |
In Thousands, unless otherwise specified | Jul. 12, 2014 | Jul. 13, 2013 |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | $320,561 | $310,090 |
Purchases of property and equipment | -106,270 | -111,904 |
Business acquisition, net of cash acquired | 2,059,184 | 187,211 |
Proceeds from Sale of Property, Plant, and Equipment | 130 | 148 |
Net Cash Provided by (Used in) Investing Activities | -2,165,324 | -282,169 |
Increase (decrease) in bank overdrafts | 6,221 | -8,724 |
Borrowings under credit facilities | 1,677,600 | 0 |
Payments on credit facilities | -862,600 | 0 |
Dividends paid | -13,178 | -13,193 |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 4,208 | 3,029 |
Tax withholdings related to the exercise of stock appreciation rights | -4,120 | -19,891 |
Excess tax benefit from share-based compensation | 5,138 | 14,570 |
Repurchase of common stock | -757 | -75,788 |
Contingent consideration related to previous business acquisition | -10,047 | -4,726 |
Other | -406 | -340 |
Net Cash Provided by (Used in) Financing Activities | 802,059 | -105,063 |
Effect of Exchange Rate on Cash and Cash Equivalents | -2,321 | 0 |
Cash and Cash Equivalents, Period Increase (Decrease) | -1,045,025 | -77,142 |
Cash and cash equivalents, beginning of period | 1,112,471 | 598,111 |
Cash and cash equivalents, end of period | 67,446 | 520,969 |
Parent Company [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 0 | ' |
Purchases of property and equipment | 0 | ' |
Business acquisition, net of cash acquired | 0 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 0 | ' |
Net Cash Provided by (Used in) Investing Activities | 0 | ' |
Increase (decrease) in bank overdrafts | 0 | ' |
Borrowings under credit facilities | 0 | ' |
Payments on credit facilities | 0 | ' |
Dividends paid | 0 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 0 | ' |
Tax withholdings related to the exercise of stock appreciation rights | 0 | ' |
Excess tax benefit from share-based compensation | 0 | ' |
Repurchase of common stock | 0 | ' |
Contingent consideration related to previous business acquisition | 0 | ' |
Other | 0 | ' |
Net Cash Provided by (Used in) Financing Activities | 0 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | 0 | ' |
Cash and Cash Equivalents, Period Increase (Decrease) | 0 | ' |
Cash and cash equivalents, beginning of period | 9 | ' |
Cash and cash equivalents, end of period | 9 | ' |
Guarantor Subsidiaries [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 318,072 | ' |
Purchases of property and equipment | -104,742 | ' |
Business acquisition, net of cash acquired | 2,058,313 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 130 | ' |
Net Cash Provided by (Used in) Investing Activities | -2,162,925 | ' |
Increase (decrease) in bank overdrafts | 6,230 | ' |
Borrowings under credit facilities | 1,677,600 | ' |
Payments on credit facilities | -862,600 | ' |
Dividends paid | -13,178 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 4,208 | ' |
Tax withholdings related to the exercise of stock appreciation rights | -4,120 | ' |
Excess tax benefit from share-based compensation | 5,138 | ' |
Repurchase of common stock | -757 | ' |
Contingent consideration related to previous business acquisition | -10,047 | ' |
Other | -406 | ' |
Net Cash Provided by (Used in) Financing Activities | 802,068 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | 0 | ' |
Cash and Cash Equivalents, Period Increase (Decrease) | -1,042,785 | ' |
Cash and cash equivalents, beginning of period | 1,106,766 | ' |
Cash and cash equivalents, end of period | 63,981 | ' |
Non-Guarantor Subsidiaries [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 2,489 | ' |
Purchases of property and equipment | -1,528 | ' |
Business acquisition, net of cash acquired | 871 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 0 | ' |
Net Cash Provided by (Used in) Investing Activities | -2,399 | ' |
Increase (decrease) in bank overdrafts | 0 | ' |
Borrowings under credit facilities | 0 | ' |
Payments on credit facilities | 0 | ' |
Dividends paid | 0 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 0 | ' |
Tax withholdings related to the exercise of stock appreciation rights | 0 | ' |
Excess tax benefit from share-based compensation | 0 | ' |
Repurchase of common stock | 0 | ' |
Contingent consideration related to previous business acquisition | 0 | ' |
Other | 0 | ' |
Net Cash Provided by (Used in) Financing Activities | 0 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | -2,321 | ' |
Cash and Cash Equivalents, Period Increase (Decrease) | -2,231 | ' |
Cash and cash equivalents, beginning of period | 5,696 | ' |
Cash and cash equivalents, end of period | 3,465 | ' |
Consolidation, Eliminations [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 0 | ' |
Purchases of property and equipment | 0 | ' |
Business acquisition, net of cash acquired | 0 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 0 | ' |
Net Cash Provided by (Used in) Investing Activities | 0 | ' |
Increase (decrease) in bank overdrafts | -9 | ' |
Borrowings under credit facilities | 0 | ' |
Payments on credit facilities | 0 | ' |
Dividends paid | 0 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 0 | ' |
Tax withholdings related to the exercise of stock appreciation rights | 0 | ' |
Excess tax benefit from share-based compensation | 0 | ' |
Repurchase of common stock | 0 | ' |
Contingent consideration related to previous business acquisition | 0 | ' |
Other | 0 | ' |
Net Cash Provided by (Used in) Financing Activities | -9 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | 0 | ' |
Cash and Cash Equivalents, Period Increase (Decrease) | -9 | ' |
Cash and cash equivalents, beginning of period | 0 | ' |
Cash and cash equivalents, end of period | ($9) | ' |